303 related articles for article (PubMed ID: 29846837)
1. Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.
Nam BD; Kim SM; Jung HN; Kim Y; Choe YH
Int J Cardiovasc Imaging; 2018 Nov; 34(11):1769-1777. PubMed ID: 29846837
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
[TBL] [Abstract][Full Text] [Related]
3. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R
BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
[TBL] [Abstract][Full Text] [Related]
5. Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltration.
Pandey T; Jambhekar K; Shaikh R; Lensing S; Viswamitra S
Int J Cardiovasc Imaging; 2013 Jan; 29(1):103-12. PubMed ID: 22527255
[TBL] [Abstract][Full Text] [Related]
6. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
Dolan RS; Stillman AE; Davarpanah AH
Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
[TBL] [Abstract][Full Text] [Related]
8. 3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.
Avitzur N; Satriano A; Afzal M; Narous M; Mikami Y; Hansen R; Dobko G; Flewitt J; Lydell CP; Howarth AG; Chow K; Fine NM; White JA
Int J Cardiovasc Imaging; 2018 Dec; 34(12):1937-1946. PubMed ID: 30014362
[TBL] [Abstract][Full Text] [Related]
9. Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.
Gotschy A; von Deuster C; van Gorkum RJH; Gastl M; Vintschger E; Schwotzer R; Flammer AJ; Manka R; Stoeck CT; Kozerke S
J Cardiovasc Magn Reson; 2019 Sep; 21(1):56. PubMed ID: 31484544
[TBL] [Abstract][Full Text] [Related]
10. Myocardial tissue characterization in patients with hereditary gelsolin (AGel) amyloidosis using novel cardiovascular magnetic resonance techniques.
Lehmonen L; Kaasalainen T; Atula S; Mustonen T; Holmström M
Int J Cardiovasc Imaging; 2019 Feb; 35(2):351-358. PubMed ID: 30848402
[TBL] [Abstract][Full Text] [Related]
11. Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters.
Pagourelias ED; Mirea O; Duchenne J; Van Cleemput J; Delforge M; Bogaert J; Kuznetsova T; Voigt JU
Circ Cardiovasc Imaging; 2017 Mar; 10(3):e005588. PubMed ID: 28298286
[TBL] [Abstract][Full Text] [Related]
12. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
13. CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis.
Korthals D; Chatzantonis G; Bietenbeck M; Meier C; Stalling P; Yilmaz A
Sci Rep; 2021 Jul; 11(1):15521. PubMed ID: 34330967
[TBL] [Abstract][Full Text] [Related]
14. Correlation between right ventricular T
Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
[TBL] [Abstract][Full Text] [Related]
16. Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.
Ando K; Nagao M; Watanabe E; Sakai A; Suzuki A; Nakao R; Ishizaki U; Sakai S; Hagiwara N
Eur Radiol; 2020 Aug; 30(8):4327-4336. PubMed ID: 32211964
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
[TBL] [Abstract][Full Text] [Related]
18. Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis.
Kim JY; Hong YJ; Han K; Lee HJ; Hur J; Kim YJ; Choi BW
Korean J Radiol; 2021 Jun; 22(6):880-889. PubMed ID: 33686816
[TBL] [Abstract][Full Text] [Related]
19. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy.
Jung HN; Kim SM; Lee JH; Kim Y; Lee SC; Jeon ES; Yong HS; Choe YH
Acta Radiol; 2020 Jul; 61(7):885-893. PubMed ID: 31684748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
